Paper of the MonthFeatured Slider
Paper of the month: Safer effective treatment for Ménière’s disease
For January 2017, we have selected: Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière’s disease: a randomized double-blind, comparative effectiveness trial. Lancet Neurol 2016;388:2753-2762.
Disabling vertigo attacks and hearing loss are characteristics of Ménière’s disease. In patients with severe and frequent vertigo spells, intratympanic injections of gentamicin have proved to be effective, but at the price of permanent vestibular damage and hearing loss.
by Gian Luigi Lenzi
A few weeks ago I was confronted with a striking consideration on the burden of scientific production in neurosciences that by no means individuals can ever be able to process and digest. Prof. Henry Markram…